There are 214 papers on preclinical Alzheimer's disease in aging research: 2 trials and 184 observational studies in people, 19 reviews. The newest story, Oct 26, 2026: “Anxiety linked to Alzheimer’s-related brain changes”.
Preclinical Alzheimer's disease is associated with poorer cognition in cognitively normal older adults and altered brain connectivity in human studies. Plasma GFAP, rest–activity fragmentation and dual-task performance are also associated with disease status. Brain atrophy results differ across studies, including a study finding no clear link when age ranges are matched.
55 findings in 41 papers from 2015 to 2026, 3 of them since April 2026
“Both participant and study partner CFI increased over the duration of the study indicating worsening cognitive functioning. Results did not differ by treatment group.”
Functional connectivity between default mode network and other networks
↓downin humans1
1 study
Preclinical Alzheimer's disease is linked with lower functional connectivity between default mode network and other networks in humans (preclinical Alzheimer's disease (Aβ+ CN)).
Functional connectivity within default mode network
↑upin humans1
1 study
Preclinical Alzheimer's disease is linked with higher functional connectivity within default mode network in humans (preclinical Alzheimer's disease (Aβ+ CN)).
Preclinical Alzheimer's disease is linked with higher interhemispheric functional connectivity difference in humans (between the first and second verbal trials).
Humansbetween the first and second verbal trialsprefrontal cortex
Preclinical Alzheimer's disease is linked with higher interhemispheric functional connectivity in humans during verbal tasks involving the first phonemic letter.
Humansduring verbal tasks involving the first phonemic letterprefrontal cortex
Preclinical Alzheimer's disease is associated with dual-task cost in humans (dual task balance condition) (mean difference 19.8, 95% CI 2.6-37.0, p = .024).
Subjective cognitive decline is associated with preclinical Alzheimer's disease in silico with subjective cognitive decline (approximately 8.4 million).
Among 1,775 older adults without cognitive impairment, anxiety-related and Alzheimer’s-related brain networks resembled each other, with a correlation of 0.74.Among 1,775 older adults without cognitive impairment, anxiety-related and Alzheimer’s-related brain networks resembled each other, with a correlation of 0.74.
A cross-sectional analysis of 15,612 adults aged 55–80 screened for Alzheimer’s trials found blood marker differences between racial and ethnic groups.A cross-sectional analysis of 15,612 adults aged 55–80 screened for Alzheimer’s trials found blood marker differences between racial and ethnic groups.
An overall thinking score matched an established measure in classifying progression to mild cognitive impairment, with a performance score of 0.70.An overall thinking score matched an established measure in classifying progression to mild cognitive impairment, with a performance score of 0.70.